Skip links

info@visionofresearch.ae

14th Floor, Dubai Science Park South Tower - Al Barsha South - Dubai - UAE

+971 425 44824

Start a Project

Academic & Research Platforms

University & Discovery-Oriented Services

1.End-to-End Research Project Design

2.Scientific Positioning & Topic Strategy

3.Hypothesis & Research Question Engineering

4.Study Methodology & Experimental Workflow

5.Statistical Design & Power Analysis

6.Biomarker, Gene & Target Strategy

7.Assay Selection & Validation Planning

8.Translational & Regulatory Alignment

9.Risk Management, Quality & Reproducibility

10.Data Analysis, Reporting & Scientific Support

1.Neurology & Neuroscience

2.Metabolic & Endocrine Models

3.Cardiovascular & Stroke Models

4.Reproductive & Fertility Models

5.Immunology & Inflammation

6.Liver & Kidney Disease Models

7.Gastrointestinal & Microbiome

8.Regenerative & Wound Healing

9.Toxicology & Safety Models

10.Ocular & Retinal Disease Models

11.Respiratory Disease Models

12.Musculoskeletal & Arthritis Models

13.Urology & Renal Function Models

14.Ocular & Retinal Disease Models

1.Learning, Memory & Cognition

2.Anxiety & Stress Behavior Assessment

3.Depression & Motivation Behavior

4.Pain & Nociception Assessment

5.Motor Function & Coordination

6.Sensorimotor Integration & Reflexes

7.Seizure & Epilepsy-Related Behavior

8.Sleep & Circadian Rhythm

9.Social Behavior & Communication

10.Reward, Addiction & Motivation

11.Fatigue & Exercise Capacity

12.Gastrointestinal & Feeding Behavior

13.Metabolic & Energy Balance

14.Urinary & Bladder Function

15.Cardiovascular Function & Stroke

16.Regenerative Functional Readouts

17.General Activity, Locomotion

Clinical Monitoring

  • General Appearance & Condition
  • Behavior & Stress Indicators
  • Grooming & Coat Condition
  • Respiratory Patterns & Function
  • Toxicity & Distress Signs
  • Body Weight & Growth Monitoring
  • Food Intake & Nutritional Status
  • Hydration & Fluid Balance

Hematological & Biochemical

  • Complete Blood Count (CBC)
  • Clinical Biochemistry Panels
  • Electrolyte

1.Gene Expression (PCR-based)

2.Nucleic Acid Extraction & Synthesis

3.Design of Nucleotide Primer Sequences

4.PCR & Advanced Molecular Analysis 

5.DNA & RNA Quantification

6.Agarose Gel Electrophoresis Performance

7.Epigenetic and DNA Methylation Assays

8.Transcriptomic and RNA-Seq Analysis

9.CRISPR-Based Genetic Validation Assays

10.Protein Expression (WB)

11.Biomarker Quantification (ELISA)

1.Cell Line Preparation & Treatment

2.Cell Viability, Proliferation & Cytotoxicity

3.Cell Migration, Invasion & Angiogenesis

4.Flow Cytometry & Cell Fate Analysis

5.Oxidative Stress & Drug Response

6.Cell Labeling, Tracking & Differentiation

7.Imaging & Microscopy

8.Organ-on-a-Chip & Advanced In-Vitro Models

9.Advanced Cellular & Molecular Platforms

10.Protein, Antibody & Omics-Related Services

1.IHC, IF & TUNEL assay

2.Fluorescent Staining Techniques

3.Specialized Staining Techniques

  • Structural and Morphological Tissue
  • Fibrosis and Extracellular Matrix
  • Neurodegeneration & Neural Integrity
  • Metabolic Changes & Lipid Accumulation
  • Mineralization and Calcification
  • Vascular Structure and Elastic Fibers
  • Inflammation & Immune Response
  • Vital Function & Cellular Differentiation
  • Microbiological Staining Techniques
  • Microscopic Imaging Platforms

1.Quantitative Analysis & Reporting

2.Tissue Evaluation & Analysis

3.Qualitative & Semi-Quantitative Analysis

4.Scientific & Regulatory Support

1.Isolation, Culture & Identification

2.Biochemical & Phenotypic Characterization

3.Antimicrobial & Antibiotic Evaluation

4.Mechanism of Action & Antimicrobial Resistance

5.Applied & Industrial Microbiology Services

1.Plant Extraction

2.Plant Extract Drying

3.Essential Oil Synthesis

4.Nanoparticle Synthesis

5.Exosome Isolation

Visionofresearch

Daily Clinical & Biochemical Monitoring

Daily clinical and behavioral monitoring, combined with systematic assessment of vital hematological and biochemical parameters, forms the essential backbone of scientific precision, safety, and ethical compliance in animal studies. This holistic approach provides structured surveillance of general condition, behavior, stress indicators, respiratory patterns, food intake, and body weight. Simultaneously, it delivers in-depth physiological evaluation through precise quantitative measurements, including hematology tests (e.g., CBC), liver and kidney function panels, metabolic and lipid profiles, and electrolyte analysis.
Regular, protocol-defined monitoring at baseline, interim, and terminal timepoints enables the early detection of physiological shifts, toxicity, or abnormal disease progression. This ensures animal welfare, supports reliable data interpretation, and delivers robust backing for informed scientific decision-making. Ultimately, this integrated monitoring strategy maintains full alignment with ethical guidelines and global regulatory standards throughout the entire study lifecycle, reinforcing the validity and impact of both academic research and preclinical drug development programs. 

  • Daily Clinical Monitorin
    1. General Appearance & Condition
    2. Behavior & Stress Indicators
    3. Grooming & Coat Condition
    4. Respiratory Patterns & Function
    5. Toxicity & Distress Signs
    6. Body Weight & Growth Monitoring
    7. Food Intake & Nutritional Status
    8. Hydration & Fluid Balance
  • Hematological & Biochemical
    1. Complete Blood Count (CBC)
    2. Clinical Biochemistry Panels
    3. Electrolyte & Mineral Balance
Send a Message

Request a Call Back

    Veterinary Industry Innovation

    1

    Baseline Clinical Profiling

    Baseline Clinical Profiling is the critical first step in any preclinical study, establishing individual reference values for each animal prior to experimental intervention. This comprehensive assessment includes a full physical exam, vital sign measurement (temperature, heart rate, respiration), behavioral evaluation, and preliminary blood sampling. It serves as an essential quality control filter, ensuring only healthy animals enter the study and providing personalized reference data to distinguish true treatment effects from normal biological variability. This process is fundamental for accurate data interpretation, animal welfare monitoring, and is a mandatory requirement for regulatory compliance with agencies like the FDA and EMA.
    Learn more
    Veterinary Industry Innovation

    2

    Daily Clinical & Behavioral Monitoring

    Protocol-defined daily monitoring is the cornerstone of animal welfare and data integrity in preclinical research. Structured, routine assessments of general appearance, behavior, stress indicators, grooming, respiration, body weight, and food intake enable continuous surveillance of animal health. This systematic approach facilitates early detection of subtle physiological or behavioral changes that may indicate toxicity, adverse effects, or disease progression. Consistent daily monitoring ensures humane endpoint adherence, supports reliable scientific conclusions, and maintains compliance with ethical and regulatory standards throughout the study lifecycle.

    Animals are assessed on a routine basis according to the approved study protocol, including:

    1. General appearance
    2. Behavior and stress indicators
    3. Grooming and coat condition
    4. Respiratory patterns
    5. Signs of toxicity or distress
    6. Body weight monitoring
    7. Food intake evaluation
    Learn more
    Veterinary Industry Innovation

    3

    Early Detection & Standardized Documentation

    Early detection and standardized documentation create a robust safety surveillance system in preclinical studies. Using predefined, objective criteria, researchers promptly identify and record any deviations from baseline or expected norms. This standardized approach ensures consistency, minimizes observer bias, and enables rapid intervention when necessary. Comprehensive documentation provides an auditable trail of animal health status, supports data interpretation, and delivers crucial evidence for regulatory submissions by demonstrating rigorous safety monitoring throughout the experimental timeline.

    Key Early Detection & Documentation Parameters:

    1. Deviation Type & Severity Grade
    2. Time of Onset & Duration
    3. Observed Clinical Signs & Description
    4. Implemented Corrective Actions & Outcome
    5. Responsible Investigator Name & Approval
    6. Reference Protocol & Checklist ID
    7. SOP / Ethical Guideline Compliance Confirmation
    Learn more
    Veterinary Industry Innovation

    4

    Hematological Profiling (CBC & Differential)

    Hematological profiling through Complete Blood Count (CBC) and differential analysis provides a detailed window into systemic health, hematopoietic function, and immune status. This evaluation quantifies red blood cells (oxygen transport), white blood cells (immune response), platelets (clotting function), and hemoglobin levels. Differential leukocyte counts further characterize immune activation by identifying specific cell type proportions. Hematological data serve as sensitive indicators of toxicity, infection, inflammation, or bone marrow suppression, making them indispensable for comprehensive safety assessment in preclinical drug development and disease modeling.Comprehensive evaluation of blood cellular components
    1. Complete Blood Count (CBC)
    2. Red Blood Cells (RBC)
    3. White Blood Cells (WBC)
    4. Hemoglobin (Hb)
    5. Hematocrit (Hct)
    6. Platelet Count (PLT)
    7. Differential Leukocyte Count
    Learn more
    Veterinary Industry Innovation

    5

    Clinical Biochemistry Panels

    Clinical biochemistry panels deliver vital insights into organ function and metabolic status through quantitative serum/plasma biomarker analysis. Liver function markers (ALT, AST, ALP) detect hepatotoxicity, while renal markers (BUN, Creatinine) assess kidney health. Metabolic indicators like fasting glucose evaluate glycemic control, and lipid profiles (TG, LDL, HDL) monitor cardiovascular risk factors. These panels provide objective, quantitative measures of systemic toxicity and physiological response to therapeutic interventions, forming an essential component of safety pharmacology and toxicology studies required for regulatory approval. Organ function and metabolic status assessment through serum and plasma biomarkers.
    • Liver Function Markers
      • ALT · AST · ALP
    • Renal Function Markers
      • Blood Urea Nitrogen (BUN)
      • Creatinine
    • Metabolic & Glycemic Indicators
      • Fasting Glucose
    • Lipid Profile
      • Triglycerides (TG)
      • Low-Density Lipoprotein (LDL)
      • High-Density Lipoprotein (HDL)
    Learn more
    Veterinary Industry Innovation

    6

    Electrolyte & Mineral Balance Assessment

    Electrolyte and mineral balance assessment evaluates fundamental physiological homeostasis crucial for cellular function and systemic stability. Precise measurement of sodium, potassium, chloride, calcium, and phosphorus levels detects imbalances that may indicate renal dysfunction, endocrine disorders, metabolic disturbances, or treatment-related toxicity. Maintaining electrolyte equilibrium is essential for neuromuscular function, fluid balance, and biochemical processes. This assessment provides critical data for understanding drug effects on physiological stability and is a key parameter in comprehensive preclinical safety evaluations. Evaluation of systemic homeostasis and physiological stability.
    • Sodium (Na)
    • Potassium (K)
    • Chloride (Cl)
    • Calcium (Ca)
    • Phosphorus (P)
    Learn more